Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities'
Portfolio Pulse from Benzinga Neuro
Jim Cramer highlighted lesser-known partners of NVIDIA Corp (NVDA) that could benefit from its AI technology, including Getty Images (GETY), Shutterstock (SSTK), Medtronic, GE HealthCare Technologies (GEHC), and Johnson & Johnson (JNJ). Despite a recent dip in NVDA's stock, Cramer believes these partnerships could lead to significant market wins.
March 20, 2024 | 3:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GE HealthCare Technologies' partnership with NVIDIA in healthcare AI has potential for future earnings growth.
GE HealthCare's collaboration with NVIDIA in healthcare AI hasn't yet translated into earnings but holds significant future potential.
CONFIDENCE 65
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Getty Images could see a turnaround from stagnant revenues through its collaboration with NVIDIA in AI.
Getty Images' collaboration with NVIDIA for training AI models using its images could lead to innovative solutions and revenue growth.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Johnson & Johnson's collaboration with NVIDIA in AI could lead to significant market wins in the healthcare sector.
Johnson & Johnson's partnership with NVIDIA in developing AI solutions for healthcare could drive long-term growth and market leadership.
CONFIDENCE 65
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
NVIDIA's partnerships and focus on AI could potentially lead to a market win, despite a recent dip in stock price.
NVIDIA's advanced AI technology and partnerships with companies across various sectors could drive future growth, offsetting any short-term stock price volatility.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Shutterstock's collaboration with NVIDIA on AI could potentially boost its performance.
Shutterstock's partnership with NVIDIA to train new AI models could enhance its offerings and drive revenue growth.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 80